Tuberculous Meningitis Clinical Trial
The study aimed to evaluate the relationships between the gene polymorphisms of leukotriene A4 hydrolase(LTA4H) and Dexamethasone treatment for tuberculous meningitis in Chinese patients.
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01371916 -
Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF
|
N/A | |
Active, not recruiting |
NCT00433719 -
Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
|
N/A | |
Completed |
NCT02237365 -
A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis
|
Phase 2 | |
Completed |
NCT03092817 -
Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
|
Phase 3 | |
Recruiting |
NCT03787940 -
Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
|
N/A | |
Not yet recruiting |
NCT05917340 -
Intensified Short Course Regimen for TBM in Adults
|
Phase 3 | |
Completed |
NCT01802502 -
Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
|
Phase 2 | |
Recruiting |
NCT05636254 -
Diagnostic Accuracy of Imaging Findings in TBM/Spinal Tubercular Arachnoiditis and Correlation With Outcomes
|
||
Recruiting |
NCT03898635 -
Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis
|
||
Completed |
NCT05781646 -
Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis (TBM) in Maharaj Nakorn Chiang Mai Hospital
|
N/A | |
Active, not recruiting |
NCT03100786 -
Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis
|
Phase 3 | |
Recruiting |
NCT04145258 -
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
|
Phase 3 | |
Recruiting |
NCT05383742 -
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
|
Phase 2 | |
Completed |
NCT03226379 -
Driving Reduced AIDS-associated Meningo-encephalitis Mortality
|
N/A | |
Recruiting |
NCT05590455 -
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
|
Phase 2 | |
Recruiting |
NCT04308928 -
Evaluation of New Biomarker-based Approaches for Improving the Diagnosis of Childhood Tuberculous Meningitis
|